These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23151972)

  • 1. Mental health disorders influence admission rates for pain in children with sickle cell disease.
    Myrvik MP; Burks LM; Hoffman RG; Dasgupta M; Panepinto JA
    Pediatr Blood Cancer; 2013 Jul; 60(7):1211-4. PubMed ID: 23151972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of psychiatric diagnoses on hospital length of stay in children with sickle cell anemia.
    Myrvik MP; Campbell AD; Davis MM; Butcher JL
    Pediatr Blood Cancer; 2012 Feb; 58(2):239-43. PubMed ID: 21425450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Admission and length of stay due to painful vasoocclusive crisis in children.
    Rogovik AL; Li Y; Kirby MA; Friedman JN; Goldman RD
    Am J Emerg Med; 2009 Sep; 27(7):797-801. PubMed ID: 19683107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Day hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease.
    Raphael JL; Kamdar A; Wang T; Liu H; Mahoney DH; Mueller BU
    Pediatr Blood Cancer; 2008 Sep; 51(3):398-401. PubMed ID: 18300322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospitalisations for sickle-cell disease in an Australian paediatric population.
    Teoh Y; Greenway A; Savoia H; Monagle P; Roy J; Barnes C
    J Paediatr Child Health; 2013 Jan; 49(1):68-71. PubMed ID: 23198729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
    Buchanan ID; Woodward M; Reed GW
    Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year review of hospital admissions among children with sickle cell disease in Kuwait.
    Akar NA; Adekile A
    Med Princ Pract; 2008; 17(5):404-8. PubMed ID: 18685282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care.
    Allen Liles E; Kirsch J; Gilchrist M; Adem M
    Hosp Pract (1995); 2014 Apr; 42(2):70-6. PubMed ID: 24769786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective evaluation of pain assessment and treatment for acute vasoocclusive episodes in children with sickle cell disease.
    Zempsky WT; Loiselle KA; McKay K; Blake GL; Hagstrom JN; Schechter NL; Kain ZN
    Pediatr Blood Cancer; 2008 Aug; 51(2):265-8. PubMed ID: 18386784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease.
    Panepinto JA; Brousseau DC; Hillery CA; Scott JP
    Pediatr Blood Cancer; 2005 Feb; 44(2):182-6. PubMed ID: 15390359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shorter hospitalization trends among children with sickle cell disease.
    Raphael JL; Mueller BU; Kowalkowski MA; Oyeku SO
    Pediatr Blood Cancer; 2012 Oct; 59(4):679-84. PubMed ID: 22223395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression and anxiety in adults with sickle cell disease: the PiSCES project.
    Levenson JL; McClish DK; Dahman BA; Bovbjerg VE; de A Citero V; Penberthy LT; Aisiku IP; Roberts JD; Roseff SD; Smith WR
    Psychosom Med; 2008 Feb; 70(2):192-6. PubMed ID: 18158366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of individualized pain plan on the emergency management of children with sickle cell disease.
    Krishnamurti L; Smith-Packard B; Gupta A; Campbell M; Gunawardena S; Saladino R
    Pediatr Blood Cancer; 2014 Oct; 61(10):1747-53. PubMed ID: 24962217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of environmental tobacco smoke on children with sickle cell disease.
    West DC; Romano PS; Azari R; Rudominer A; Holman M; Sandhu S
    Arch Pediatr Adolesc Med; 2003 Dec; 157(12):1197-201. PubMed ID: 14662575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease.
    Stallworth JR; Jerrell JM; Tripathi A
    Am J Hematol; 2010 Oct; 85(10):795-7. PubMed ID: 20645429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Geographic Characterization of 30-Day Readmissions in Pediatric Sickle Cell Crisis Patients.
    McMillan JE; Meier ER; Winer JC; Coco M; Daymont M; Long S; Jacobs BR
    Hosp Pediatr; 2015 Aug; 5(8):423-31. PubMed ID: 26231632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of deep sedation in young children with sickle cell disease: a retrospective cohort study.
    Belmont AP; Nossair F; Brambilla D; Friedman M; Boswinkel J; Bradford AB; Kwiatkowski JL
    J Pediatr; 2015 May; 166(5):1226-32. PubMed ID: 25919732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in hospital admissions for sickle cell disease in England, 2001/02-2009/10.
    Aljuburi G; Laverty AA; Green SA; Phekoo KJ; Banarsee R; Okoye NV; Bell D; Majeed A
    J Public Health (Oxf); 2012 Dec; 34(4):570-6. PubMed ID: 22653886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
    Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital.
    Raphael JL; Kamdar A; Beavers MB; Mahoney DH; Mueller BU
    Pediatr Blood Cancer; 2008 Jul; 51(1):82-5. PubMed ID: 18383165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.